The effect of crocin and losartan on TGF-β gene expression and histopathology of kidney tissue in a rat model of diabetic nephropathy | ||
Avicenna Journal of Phytomedicine | ||
دوره 13، شماره 2، خرداد و تیر 2023، صفحه 189-199 اصل مقاله (1.16 M) | ||
نوع مقاله: Original Research Article | ||
شناسه دیجیتال (DOI): 10.22038/ajp.2022.21414 | ||
نویسندگان | ||
Yaser Mohammadi1؛ Mohammad Zangooei2؛ Mahmoud Zardast3؛ Morteza Mamashli2؛ Azam Rezaei Farimani* 4 | ||
1Qaen School of Nursing and Midwifery, Birjand University of Medical Sciences, Birjand, Iran | ||
2Department of Clinical Biochemistry, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran | ||
3Medical Toxicology and Drug Abuse Research Center, Department of Pathology, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran | ||
4Cardiovascular Diseases Research center, Birjand University of Medical Sciences, Birjand, Iran | ||
چکیده | ||
Objective: Diabetic nephropathy is one of the most common microvascular complications of diabetes mellitus that finally leads to complete loss of kidney function. Therefore, this study aimed to evaluate the effect of crocin and losartan on TGF-β gene expression and histopathology of kidney tissue in a rat model of diabetic nephropathy. Materials and Methods: Forty male Wistar rats were randomly divided into five groups (n=8): Untreated control, Diabetic (D), D + crocin, D + losartan, and D + losartan + crocin. Induction of diabetes was performed using streptozotocin (50 mg/kg/ Intraperitoneal injection). At the end of the eight-week period, the rats were sacrificed. Spectrophotometry measured serum glucose, urea, creatinine, and uric acid levels. Microalbumin and creatinine levels were measured in 24-hour urine. Real-time PCR was used to determine the relative expression of the TGF-β gene in kidney tissue. Renal tissue histopathology was also examined. Results: The results showed that hyperglycemia increased biochemical factors associated with diabetes, TGF-β gene expression, and kidney damage. Separate treatment with crocin and losartan led to a decrease in renal function factors and TGF-β gene expression and improved kidney damage. Conclusion: Our results showed that crocin could improve kidney function in diabetic conditions. In addition, we showed that crocin increases the effectiveness of losartan. Consequently, we suggest that crocin in combination with chemical drugs can be a potential therapeutic agent for diabetes and its complications. Nonetheless, human studies are needed to make firm findings. | ||
کلیدواژهها | ||
Diabetic nephropathy؛ Crocin؛ Losartan؛ Kidney؛ TGF-β | ||
مراجع | ||
Abou Hany HO, Atef H, Said E, Elkashef HA, Salem HA. 2018. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats. Chem Biol Interact, 284: 90-100. Ali Hammood Keelo RM, Elbe H, Bicer Y, Yigitturk G, Koca O, Karayakali M, Acar D, Altinoz E. 2022. Treatment with crocin suppresses diabetic nephropathy progression via modulating TGF-β1 and oxidative stress in an experimental model of pinealectomized diabetic rats. Chem Biol Interact, 351: 109733. Alotaibi MR, Fatani A, Almnaizel AT, Ahmed M, Abuohashish HM, Al-Rejaie S. 2019. In vivo assessment of combined effects of glibenclamide and losartan in diabetic rats. J Health Sci, 28: 178-185. Anbar HS, Shehatou GS, Suddek GM, Gameil NM. 2016. Comparison of the effects of levocetirizine and losartan on diabetic nephropathy and vascular dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol, 780: 82-92. Ashrafi M, Nazifi S, Namazi F, Kazemipour N, Karimi B, Goudarzi T, Talebanzadeh S. 2017. Renal protective effect of saffron aqueous extract in streptozotocin induced diabetic rats. Int J Med Sci Public Health, 6: 151-161. Dou F, Liu Y, Liu L, Wang J, Sun T, Mu F, Guo Q, Guo C, Jia N, Liu W, Ding Y, Wen A. 2019. Aloe-emodin ameliorates renal fibrosis via inhibiting PI3K/Akt/mTOR signaling pathway in vivo and in vitro. Rejuvenation Res, 22: 218-229. ElFawal R, ElFayoumi HM, Mahmoud MF. 2018. Diosmin and crocin alleviate nephropathy in metabolic syndrome rat model: Effect on oxidative stress and low grade inflammation. Biomed Pharmacother, 102: 930-937. Farshid AA, Tamaddonfard E, MoradiArzeloo M, Mirzakhani N. 2016. The effects of crocin, insulin and their coadministration on the heart function and pathology in streptozotocin-induced diabetic rats. Avicenna J Phytomed, 6: 658-670. Faten A, Mohammad M, Salah E. 2021. Role of angiotensin II and renal nerves on TGFb/smadpathway in diabetic nephropathy rat model. Med J Cairo Univ, 89: 399-408. Ghorbanzadeh V, Mohammadi M, Dariushnejad H, Chodari L, Mohaddes G. Mohammadi et al. AJP, Vol. 13, No. 2, Mar-Apr 2023 198 2016. Effects of crocin and voluntary exercise, alone or combined, on heart VEGF-A and HOMA-IR of HFD/STZ induced type 2 diabetic rats. J Endocrinol Investig, 39: 79-86. Hoogeveen EK. 2022. The epidemiology of diabetic kidney disease. Kidney Dial, 2: 433-442. Hussain MA, Abogresha NM, AbdelKader G, Hassan R, Abdelaziz EZ, Greish SM. 2021. Antioxidant and anti-inflammatory effects of crocin ameliorate doxorubicininduced nephrotoxicity in rats. Oxid Med Cell Longev, 15: 82-88. Isaka Y. 2018. Targeting TGF-β signaling in kidney fibrosis. Int J Mol Sci, 19: 2532. Kaur M, Sachdeva S, Bedi O, Kaur T, Kumar P. 2015. Combined effect of hydrogen sulphide donor and losartan in experimental diabetic nephropathy in rats. J Diabetes Metab Disord, 14: 63. Liu Q, Lv S, Liu J, Liu S, Wang Y, Liu G. 2020. Mesenchymal stem cells modified with angiotensin-converting enzyme 2 are superior for amelioration of glomerular fibrosis in diabetic nephropathy. J Diabetes Res, 162: 93-108. Mullen AC, Wrana JL. 2017. TGF-β family signaling in embryonic and somatic stemcell renewal and differentiation. Cold Spring Harb Perspect Biol, 9: a022186. Natesan V, Kim SJ. 2021. Diabetic nephropathy - a review of risk factors, progression, mechanism, and dietary management. Biomol Ther, 29: 365-372. Ni WJ, Tang LQ, Wei W. 2015. Research progress in signalling pathway in diabetic nephropathy. Diabetes Metab Res Rev, 31: 221-233. Peruchetti DB, Barahuna-Filho PFR, SilvaAguiar RP, Abreu TP, Takiya CM, Cheng J, Pinheiro AS, Cebotaru L, Guggino WB, Caruso-Neves C. 2021. Megalin-mediated albumin endocytosis in renal proximal tubules is involved in the antiproteinuric effect of angiotensin II type 1 receptor blocker in a subclinical acute kidney injury animal model. Biochim Biophys Acta Gen Subj, 1865: 129950. Piccoli GB, Grassi G, Cabiddu G, Nazha M, Roggero S, Capizzi I, De Pascale A, Priola AM, Di Vico C, Maxia S, Loi V, Asunis AM, Pani A, Veltri A. 2015. Diabetic kidney disease: A syndrome rather than a single disease. Rev Diabet Stud, 12: 87- 109. Rajaei Z, Hadjzadeh MA, Nemati H, Hosseini M, Ahmadi M, Shafiee S. 2013. Antihyperglycemic and antioxidant activity of crocin in streptozotocin-induced diabetic rats. J Med Food, 16: 206-210. Samadi-Noshahr Z, Ebrahimzadeh B, Hadjzadeh A, Shafei M, Salmani MN, Hosseinian H, Khajavi Rad S. 2021. Trans-anethole attenuated renal injury and reduced expressions of angiotensin II receptor (AT1R) and TGF-β in streptozotocin-induced diabetic rats. Biochimie, 185: 117-127. Samarghandian S, Aziminezhad M, Farkhondeh T. 2016. Crocin attenuate tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) in streptozotocininduced diabetic rat aorta. Cytokine, 88: 20-28. Sefidgar SM, Ahmadi-Hamedani M, Jebelli Javan A, Narenjisani R, Javaheri A. 2019. Effect of crocin on biochemical parameters, oxidative/antioxidative profiles, sperm characteristics and testicular histopathology in streptozotocininduced diabetic rats. Avicenna J Phytomed, 9: 347-361. Shi GJ, Shi GR, Zhou JY, Zhang WJ, Gao CY, Jiang YP, Zi ZG, Zhao HH, Yang Y, Yu JQ. 2018. Involvement of growth factors in diabetes mellitus and its complications: a general review. Biomed Pharmacother, 101: 510-527. Shirali S, Bathaie SZ, Nakhjavani M. 2013. Effect of crocin on the insulin resistance and lipid profile of streptozotocin-induced diabetic rats. Phytother Res, 27: 1042- 1047. Talebanzadeh S, Ashrafi M, Kazemipour N, Erjaee H, Nazifi S. 2018. Evaluation of the effects of saffron aqueous extract on oxidative stress in the lens of streptozotocin-induced diabetic rats. Biomed Res Ther, 5: 2133-2141. Teles F, Machado FG, Ventura BH, Malheiros DM, Fujihara CK, Silva LF, Zatz R. 2009. Regression of glomerular injury by losartan in experimental diabetic nephropathy. Kidney Int, 75: 72-79. Xi L, Qian Z. 2006. Pharmacological properties of crocetin and crocin (digentiobiosyl ester of crocetin) from saffron. Nat Prod Commun, 1: 65-75. Xu ZJ, Shu S, Li ZJ, Liu YM, Zhang RY. Effect of crocin and losartan on diabetic nephropathy AJP, Vol. 13, No. 2, Mar-Apr 2023 199 2017. Liuwei dihuang pill treats diabetic nephropathy in rats by inhibiting of TGFβ/SMADS, MAPK, and NF-kB and upregulating expression of cytoglobin in renal tissues. Medicine (Baltimore), 96: e5879. Yang CC, Chen YT, Chen CH, Li YC, Shao PL, Huang TH, Chen YL, Sun CK, Yip HK. 2019. The therapeutic impact of entresto on protecting against cardiorenal syndrome-associated renal damage in rats on high protein diet. Biomed Pharmacother, 116: 108954. Yaribeygi H, Mohammadi MT, Rezaee R, Sahebkar A. 2018. Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy. J Cell Biochem, 119: 6080-6093. Zhang F, Liu H, Liu D, Liu Y, Li H, Tan X, Liu F, Peng Y, Zhang H. 2017. Effects of RAAS inhibitors in patients with kidney disease. Curr Hypertens Rep, 19: 72. | ||
آمار تعداد مشاهده مقاله: 11,058 تعداد دریافت فایل اصل مقاله: 604 |